BeStock  
Stocks › Biotechnology › NBTX

Nanobiotix NBTX

US equityMarket cap rank #2958Biotechnology
$26.50 −$0.82 (-2.98%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $26.50 0.00%
Open$28.15
Prev close$27.32
Day range$26.12 – $28.60
Volume125.3K
Market cap$1.35B
P/E (TTM)–
Dividend yield–

Fundamentals

Latest reported quarter: ANNUAL, ended Dec 2025 · reported in EUR

Revenue€29.64M+355.3% YoY
Operating profit-€10.82M+84.2% YoY
Net profit-€23.96M+64.8% YoY
Diluted EPS-€0.50+65.3% YoY

Annual revenue

€50.0KFY20€10.0KFY21€0.0FY22€30.1MFY23€-11.6MFY24€29.6MFY25

Profitability & balance sheet

Operating margin-353.6%
Net margin-632.5%
Return on assets-60.9%
Current ratio1.44
Liabilities / assets126.0%
Cash & investments€110.89M
Total debt€105.38M
Net cash (debt)€5.51M

Where the revenue comes from

Quarter 2025/FY

By business line

  • Services€22.68M 76.5%
  • Other Sales€6.96M 23.5%

This company reports in its own local currency, not U.S. dollars. Every figure below is labeled with its real currency, not automatically converted.

Balance sheet

Line item 2026 Q2
(EUR)
2025 ANNUAL
(EUR)
2025 Q4
(EUR)
2025 Q2
(EUR)
2024 ANNUAL
(EUR)
Total Assets €128.33M €67.76M €67.76M €45.17M €67.42M
Total Current Assets €123.48M €62.75M €62.75M €39.89M €61.47M
Cash and Cash Equivalents & Short-Term Investments €110.89M €52.75M €52.75M €28.82M €49.74M
-Cash and Cash Equivalents €110.89M €52.75M €52.75M €28.82M €49.74M
Receivables €9.37M €7.68M €7.68M €9.15M €8.54M
-Accounts Receivable €1.93M €2.14M €2.14M €1.84M €2.98M
-Taxes Receivable €6.22M €4.12M €4.12M €5.98M €4.47M
-Other Receivables €1.22M €1.43M €1.43M €1.33M €1.09M
Prepaid Assets €3.22M €2.32M €2.32M €1.93M €3.20M
Total Non-Current Assets €4.85M €5.01M €5.01M €5.28M €5.95M
Net PPE €4.41M €4.57M €4.57M €4.86M €5.54M
-Gross PPE €17.64M €17.01M €17.01M €16.50M €16.56M
-Accumulated Depreciation -€13.23M -€12.44M -€12.44M -€11.64M -€11.02M
Non-Current Prepaid Assets €409,000.00 €409,000.00 €409,000.00 €409,000.00 €406,000.00
Goodwill and Other Intangible Assets €7,000.00 €10,000.00 €10,000.00 €13,000.00 €7,000.00
-Other Intangible Assets €7,000.00 €10,000.00 €10,000.00 €13,000.00 €7,000.00
Other Non-Current Assets €25,000.00 €25,000.00 €25,000.00 -€1,000.00 –
Total Liabilities €161.71M €152.24M €152.24M €114.13M €133.12M
Total Current Liabilities €85.93M €57.51M €57.51M €63.04M €58.94M
Payables €11.73M €14.01M €14.01M €11.23M €12.03M
-Accounts Payable €6.16M €6.58M €6.58M €4.23M €4.48M
-Total Tax Payable €5.39M €6.82M €6.82M €6.29M €6.87M
-Other Payable €179,000.00 €613,000.00 €613,000.00 €714,000.00 €672,000.00
Current Accrued Expenses €2.61M €2.54M €2.54M €7.41M €15.55M
Short-Term Debt and Capital Lease Obligation €32.07M €4.31M €4.31M €4.74M €4.92M
-Current Debt €30.83M €3.10M €3.10M €3.49M €3.66M
-Current Capital Lease Obligation €1.23M €1.21M €1.21M €1.25M €1.26M
Current Provisions €60,000.00 €118,000.00 €118,000.00 €167,000.00 €438,000.00
Current Deferred Liabilities €36.17M €36.22M €36.22M €36.22M €18.16M
Other Current Liabilities €3.30M €312,000.00 €312,000.00 €3.27M €7.84M
Total Non-Current Liabilities €75.78M €94.74M €94.74M €51.09M €74.19M
Long Term Debt and Capital Lease Obligation €74.55M €91.01M €91.01M €46.51M €45.98M
-Long Term Debt €73.28M €89.12M €89.12M €44.12M €43.01M
-Long Term Capital Lease Obligation €1.27M €1.89M €1.89M €2.39M €2.97M
Employee Benefits €556,000.00 €507,000.00 €507,000.00 €479,000.00 €432,000.00
Other Non-Current Liabilities €678,000.00 €3.22M €3.22M €4.11M €27.78M
Total Equity -€33.38M -€84.48M -€84.48M -€68.95M -€65.70M
Stockholders' Equity -€33.38M -€84.48M -€84.48M -€68.95M -€65.70M
Capital Stock €1.53M €1.45M €1.45M €1.45M €1.42M
-Common Stock €1.53M €1.45M €1.45M €1.45M €1.42M
Additional Paid-In Capital €396.87M €314.40M €314.40M €312.74M €312.74M
Retained Earnings -€34.29M -€23.96M -€23.96M -€5.38M -€68.13M
Less: Treasury Stock -€228,000.00 -€228,000.00 -€228,000.00 -€228,000.00 -€228,000.00
Gains/Losses Not Affecting Retained Earnings -€397.26M -€376.15M -€376.15M -€377.53M -€311.51M
Other Current Assets – €2,000.00 €2,000.00 – -€1,000.00

Income statement

Line item 2025 ANNUAL
(EUR)
2024 ANNUAL
(EUR)
2023 ANNUAL
(EUR)
2022 ANNUAL
(EUR)
2021 ANNUAL
(EUR)
Total Revenue as Reported €29.64M -€11.61M €30.06M €0.00 €2.65M
Total Operating Revenue €29.64M -€11.61M €30.06M €0.00 €10,000.00
Operating Expense €40.46M €56.78M €56.84M €46.70M €52.59M
Selling and Admin Expenses €20.22M €20.06M €21.66M €17.48M €19.02M
-General & Admin Expense €20.22M €20.06M €21.66M €17.48M €19.02M
Research & Development €23.12M €40.54M €38.40M €32.64M €30.38M
Depreciation & Amortization & Depletion €345,000.00 €319,000.00 €270,000.00 €335,000.00 €416,000.00
-Depreciation & Amortization €345,000.00 €319,000.00 €270,000.00 €335,000.00 €416,000.00
Other Taxes -€2.82M -€3.30M -€3.94M -€4.09M -€2.49M
Other Operating Expenses -€404,000.00 -€837,000.00 €448,000.00 €343,000.00 €5.27M
Operating Profit -€10.82M -€68.39M -€26.78M -€46.70M -€52.58M
Net Non-Operating Interest Income (Expense) -€9.91M -€2.63M -€6.48M -€12.44M -€658,000.00
Non-Operating Interest Income €985,000.00 €2.63M €1.22M €256,000.00 €0.00
Non-Operating Interest Expense €10.40M €8.09M €7.98M €5.84M €671,000.00
Total Other Finance Costs €496,000.00 -€2.83M -€285,000.00 €6.86M -€13,000.00
Other Income (Expense) -€3.23M €2.99M -€6.32M €2.11M €6.24M
Gain on Sale of Security -€3.23M €2.99M -€6.32M €2.11M €6.24M
Pretax Profit -€23.96M -€68.03M -€39.58M -€57.03M -€47.00M
Tax €3,000.00 €101,000.00 €120,000.00 €10,000.00 €5,000.00
Net Profit -€23.96M -€68.13M -€39.70M -€57.04M -€47.00M
Profit from Continuing Operations -€23.96M -€68.13M -€39.70M -€57.04M -€47.00M
Net Income to Parent Company -€23.96M -€68.13M -€39.70M -€57.04M -€47.00M
Net Income to Common Stockholders -€23.96M -€68.13M -€39.70M -€57.04M -€47.00M
Basic EPS -€0.50 -€1.44 -€1.08 -€1.64 -€1.35
Diluted EPS -€0.50 -€1.44 -€1.08 -€1.64 -€1.35
Special Income (Charges) – – – – €0.00

Cash flow

Line item 2025 ANNUAL
(EUR)
2024 ANNUAL
(EUR)
2023 ANNUAL
(EUR)
2022 ANNUAL
(EUR)
2021 ANNUAL
(EUR)
Operating Cash Flow -€33.42M -€19.55M -€12.48M -€37.10M -€29.87M
Net cash flow from continuing operations -€33.42M -€19.55M -€12.48M -€37.11M -€29.87M
Net Income from Continuing Operations -€23.96M -€68.13M -€39.70M -€57.04M -€47.00M
Gain/Loss from Continuing Operations €153,000.00 -€3,000.00 -€24,000.00 €3,000.00 –
Depreciation & Depletion & Amortization €1.50M €1.62M €1.51M €1.50M €1.56M
Deferred Tax €3,000.00 €101,000.00 €120,000.00 €0.00 €0.00
Other Non-Cash Items -€10.83M €28.61M €11.97M €12.66M €678,000.00
Change in Working Capital -€3.40M €14.28M €9.92M €2.30M €11.54M
-Change in Receivables €1.85M €355,000.00 -€1.09M -€1.83M -€3.05M
-Change in Payables and Accrued Expense -€5.41M €1.96M €8.68M €2.91M -€281,000.00
-Change in Other Current Liabilities €175,000.00 -€224,000.00 €723,000.00 €1.22M -€1.65M
-Change In Other Working Capital -€16,000.00 €12.19M €1.61M – €16.52M
Net cash flow from investing -€578,000.00 -€955,000.00 -€349,000.00 €138,000.00 -€242,000.00
Net Cash Flow from Continuing Investing Activities -€578,000.00 -€955,000.00 -€349,000.00 €137,000.00 -€242,000.00
Net PPE Purchase and Sale -€538,000.00 -€846,000.00 -€328,000.00 -€92,000.00 -€228,000.00
Net Intangibles Purchase and Sale -€8,000.00 -€2,000.00 -€9,000.00 -€1,000.00 -€5,000.00
Net Investment Purchase and Sale -€32,000.00 -€107,000.00 -€12,000.00 €230,000.00 -€9,000.00
Financing Cash Flow €37.42M -€5.14M €46.77M -€5.65M -€5.18M
Net Cash Flow from Continuing Financing Activities €37.42M -€5.14M €46.77M -€5.65M -€5.18M
Net Issuance Payments Of Debt €38.19M -€4.16M -€3.62M -€4.74M -€3.74M
Net Common Stock Issuance €1.54M €0.00 €60.15M €0.00 €0.00
Cash Dividends Paid €0.00 €0.00 €0.00 €0.00 €0.00
Net Other Financing Charges -€778,000.00 – -€2.79M -€1,000.00 -€349,000.00
Ending Cash Balance €52.75M €49.74M €75.28M €41.39M €83.92M
Net Change in Cash €3.42M -€25.64M €33.95M -€42.62M -€35.29M
Beginning Cash Balance €49.74M €75.28M €41.39M €83.92M €119.15M
Effect of Exchange Rate Changes -€402,000.00 €94,000.00 -€51,000.00 €83,000.00 €64,000.00
Free Cash Flow -€33.97M -€20.40M -€12.81M -€37.20M -€30.11M
Net Other Investing Changes – – – €1,000.00 –
Proceeds from Stock Option Exercised – – – – €43,000.00

Discussion

No comments yet — be the first to weigh in on NBTX.

Sign in to join the discussion.

Scroll to Top